D-0520-2022 Class II Terminated

Recalled by Teva Pharmaceuticals USA — Parsippany, NJ

Recall Details

Product Type
Drugs
Report Date
February 9, 2022
Initiation Date
January 10, 2022
Termination Date
December 21, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1,175 Bottles

Product Description

Tretinoin Capsules, 10 mg, 100 count bottle, Rx Only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0555-0808-02

Reason for Recall

Failed Dissolution Specifications; Low Out of specification (OOS) results for dissolution.

Distribution Pattern

nationwide in the USA

Code Information

Lot #: 100022970, Exp. 08/2022